JW Asset Management’s Novelion Therapeutics Inc. Common Shares NVLN Stock Holding History

JW Asset Management’s Portfolio NVLN Stock Details NVLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-315,979	Closed	-$389K	–	19
2019 Q1	$389K	Hold	315,979	–	–	0.2%	16
2018 Q4	$265K	Hold	315,979	–	–	0.2%	16
2018 Q3	$935K	Hold	315,979	–	–	0.5%	13
2018 Q2	$1.16M	Hold	315,979	–	–	0.74%	16
2018 Q1	$1.11M	Hold	315,979	–	–	1.09%	17
2017 Q4	$986K	Sell	315,979 -1	-0%	-$5	1.05%	17
2017 Q3	$2.22M	Hold	315,980	–	–	1.63%	14
2017 Q2	$2.92M	Buy	315,980 +5,681	+2%	+$54.7K	1.86%	13
2017 Q1	$3.33M	Sell	310,299 -13,981	-4%	-$143K	0.69%	15
2016 Q4	$2.73M	Buy	+324,280	New	+$2.87M	1.82%	14

Other funds holding NVLN

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return

HVC

Healthcare Value Capital Woodcliff Lake, New Jersey $50.7M AUM 24.72% 1-Year Est. Return

HCM

Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

DMK

David M. Knott $275M AUM 59.23% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

FSA

Franklin Street Advisors Chapel Hill, North Carolina $1.79B AUM 28.1% 1-Year Est. Return

JW Asset Management's NVLN Position: Q2 2019 in Review

JW Asset Management sold out of Novelion Therapeutics Inc. Common Shares (NVLN) in Q2 2019, closing a stake of 315,979 shares — an estimated $389K sold.

JW Asset Management first reported a position in NVLN in Q4 2016 and held it in 10 quarters. The position peaked at $3.33M in Q1 2017. 35 funds tracked by Wall St. Rank hold NVLN as of Q2 2019.

JW Asset Management reported no remaining Novelion Therapeutics Inc. Common Shares position as of Q2 2019 after selling out during the quarter.
JW Asset Management sold 315,979 Novelion Therapeutics Inc. Common Shares shares in Q2 2019, an estimated $389K.
JW Asset Management first reported a position in Novelion Therapeutics Inc. Common Shares in Q4 2016 and held it in 10 quarters.
JW Asset Management's Novelion Therapeutics Inc. Common Shares position peaked at $3.33M in Q1 2017.
35 funds tracked by Wall St. Rank held Novelion Therapeutics Inc. Common Shares as of Q2 2019.

Based on JW Asset Management's 13F filing for Q2 2019, filed 9 Aug 2019.